Annual Performance Review FY25.
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Black Rose Industries reported its highest-ever standalone turnover of ₹346.32 crore in FY25, up 21.5% year-on-year, driven by strong demand in both its distribution and manufacturing businesses. Standalone PAT grew 31.4% to ₹26.84 crore, while EBITDA rose 21.6% to ₹38.36 crore, with EBITDA margin nudging up to 11.37% from 11.22%. The distribution division led growth with a 29% rise in value and 10% in volumes, while manufacturing saw strong contributions from N-methylol acrylamide (NMA) and acrylamide solid. The company inaugurated a new R&D facility in Navi Mumbai, is nearing registration of a strategic land parcel, and expects environmental clearance soon for its brownfield specialty chemicals expansion at Jhagadia. ROCE improved to 21.30%, though debt-to-equity ticked up to 0.059 from 0.013 due to expansion funding.
Positive for shareholders — record revenues, strong profit growth, improving returns on capital, and visible capex pipeline (R&D, brownfield expansion, polyacrylamide solids project) point to healthy momentum, though higher gearing and a modest Q4 export dip due to U.S. tariff uncertainty are minor watchpoints.